DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Telaprevir
Telaprevir
Telaprevir (Incivek)
Telaprevir for HIV/Hepatitis C Virus–Coinfected Patients Failing
The Legally Binding Text Is the Original French Version TRANSPARENCY
Caracterización Molecular Del Perfil De Resistencias Del Virus De La
PASS Information
Medicinal Product No Longer Authorised
PASS Information Title Cilostazol Drug Utilisation Study
Inhibitor Development Against P7 Channel in Hepatitis C Virus
Symmetrel (Amantadine)
Usage of Antivirals and the Occurrence of Antiviral Resistance in Norway 2018
Estonian Statistics on Medicines 2013 1/44
New Agents for the Treatment of Hepatitis C Virus – Focus on Telaprevir
Simeprevir (Olysio)
Review Telaprevir: Pharmacokinetics and Drug Interactions
Drug Interactions with Hepatitis C Virus NS3/4A Protease Inhibitors and HIV Medications: a Quick Guide for Clinicians
EPCLUSA (Sofosbuvir and Velpatasvir)
Amantadine May Lower the Efficacy of Pegylated Interferon Plus Ribavirin In
Olysio ®) SMC No
Top View
Who Drug Information
Incivo, INN-Telaprevir
Computational Drug Repurposing Study Elucidating Simultaneous Inhibition of Entry and Replication of Novel Corona Virus by Grazoprevir
Hepatitis C Virus Protease Inhibitors Show Differential Efficacy and Interactions with Remdesivir for Treatment of SARS-Cov-2 in Vitro
The Netherlands Hepatitis C Treatment Guidelines
ATC-Index Mit DDD-Angaben Für Den Deutschen Arzneimittelmarkt Berlin 2013, 12
Prediction of Sustained Virological Response to Telaprevir/Simeprevir
Original Article Investigation of Viral Escape Mutations Within HCV P7 During Treatment with Amantadine in Patients with Chronic Hepatitis C
Small Molecule Degraders of the Hepatitis C Virus Protease Reduce Susceptibility to Resistance Mutations
Olysio (Simeprevir)
Telaprevir (Incivek®) UTILIZATION MANAGEMENT CRITERIA
Treatment of Hepatitis C with Pegylated Interferon and Ribavirin, with Or Without Boceprevir Or Telaprevir
Mutagénesis Letal Del Virus De La Hepatitis C
Remdesivir from Wikipedia, the Free Encyclopedia
Telaprevirbased Triple Therapy in Liver Transplant Patients with Hepatitis C
(12) United States Patent (10) Patent No.: US 8,546.432 B2 Bahadoor Et Al
New Data on Telaprevir and VX-222 for the Treatment of Hepatitis C Accepted for Presentation at EASL Annual Meeting
Anti-Infectives for Systemic Use Prescribed in a Spanish Hospital Between 2009‑2013
Boceprevir and Telaprevir for Chronic Genotype 1 Hepatitis C Virus Infection
INCIVEK (Telaprevir) Tablets Pregnancy Category B: Telaprevir Treatment Alone in Mice and Rats Did Not Result in Harm to the Fetus
201917Orig1s000
PDF Document: Ribacip (Ribavirin)
Synergy of Entry Inhibitors with Direct-Acting Antivirals Uncovers Novel Combinations for Prevention and Treatment of Hepatitis
Review Review of Drug Interactions with Telaprevir and Antiretrovirals
Program and Abstracts International Conference Antiviral Research
A Structured Review of Approaches for Establishing and Evaluating Clinical Relevance of Drug Interactions in Patients with Hepatitis C Virus Genotype 1
HCV NS3 Protease Inhibitors Telaprevir and Boceprevir
Us 2019 / 0127401 A1
Vertex Provides Update to Ongoing Phase 2 Study Evaluating Combinations of Telaprevir and VX-222 for the Treatment of Hepatitis C
Hepatitis C Treatment Factsheet Telaprevir (Incivo)
Dosing Tables
Pharmacogenetics Approach for the Improvement of COVID-19 Treatment
ESAC-Net Reporting Protocol 2018.Docx Introduction